Vivo Bio Tech Limited has announced the expiry of 6,27,409 Convertible Equity Warrants. These warrants, part of a larger issuance of 25,00,000 warrants allotted on February 24, 2025, were not exercised before their expiry date of August 24, 2026. The warrants were issued at a price of Rs. 45/- each. This event signifies a reduction in potential future share dilution.
Warrant Expiry Update
Vivo Bio Tech Limited has formally informed stakeholders about the expiry of a substantial portion of its outstanding Convertible Equity Warrants. A total of 6,27,409 warrants, out of the 25,00,000 initially issued, have expired due to non-exercise by the allottee, Dwight Technologies Private Limited. These warrants were originally allotted on February 24, 2025.
Warrant Details and Expiry
The warrants carried a face value of Rs. 10/- and a premium of Rs. 35/-, with an issue price of Rs. 45/- per warrant. The expiry date was August 24, 2026, marking the end of the eighteen-month tenure from the allotment date. The non-exercise of these warrants means that the associated capital infusion will not occur, and potential share dilution is averted.
Source: BSE
